BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8153396)

  • 21. [The heart in systemic lupus erythematosus. Study in 32 non-selected patients (author's transl)].
    Gobaira Maluf J; Zghaib Abad A; Reyes López PA
    Arch Inst Cardiol Mex; 1982; 52(3):223-8. PubMed ID: 6214224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of cardiac involvement in neonatal lupus.
    Hornberger LK; Al Rajaa N
    Scand J Immunol; 2010 Sep; 72(3):189-97. PubMed ID: 20696015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of mothers of children with isolated heart block in Finland.
    Julkunen H; Eronen M
    Arthritis Rheum; 2001 Mar; 44(3):647-52. PubMed ID: 11263779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
    Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive strategies in systemic lupus erythematosus.
    Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P
    Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features of preterm infants born to mothers with systemic lupus erythematosus: a retrospective analysis].
    Quan MY; Wang DH
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1045-9. PubMed ID: 24342193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic lupus erythematosus. Association with previous neonatal lupus erythematosus.
    Fox RJ; McCuistion CH; Schoch EP
    Arch Dermatol; 1979 Mar; 115(3):340. PubMed ID: 434854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy.
    Ono K; Tohjima T; Komazawa T
    Clin Orthop Relat Res; 1992 Apr; (277):89-97. PubMed ID: 1555361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial systemic lupus erythematosus and congenital infection-like syndrome.
    Dale RC; Tang SP; Heckmatt JZ; Tatnall FM
    Neuropediatrics; 2000 Jun; 31(3):155-8. PubMed ID: 10963105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [When to think about lupus?].
    Arnaud L; Mathian A; Amoura Z
    Rev Prat; 2011 Nov; 61(9):1254-6, 1258. PubMed ID: 22308810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient Lambert-Eaton myasthenic syndrome associated with systemic lupus erythematosus.
    Bromberg MB; Albers JW; McCune WJ
    Muscle Nerve; 1989 Jan; 12(1):15-9. PubMed ID: 2747733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.